Malladi Drugs & Pharmaceuticals Pvt Ltd

FDA inspection history across 2 sites, 2018 to 2019

1
Close-out
1
Form 483

Every document, by year

  • Close-out
  • Form 483

2018: one Form 483; 2019: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–19One Form 483 and one close-out letter, at GajuJamandyant, India and Bhiwadi, India.

Cited most

Across all Malladi Drugs & Pharmaceuticals Pvt observations on file

The complete Malladi Drugs & Pharmaceuticals Pvt file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2019-03-21Close-out Close-out letter$99
2018-10-09483 Form 483$99

Investigators on these documents

Kellia N. Hicks (1)

FEI number 3010212308 · most recent document Mar 21, 2019

About Malladi Drugs & Pharmaceuticals Pvt Ltd

How many FDA Form 483s has Malladi Drugs & Pharmaceuticals Pvt Ltd received?

FDA Intel has 1 Form 483 on file for Malladi Drugs & Pharmaceuticals Pvt Ltd; the most recent is dated Oct 9, 2018.

When was Malladi Drugs & Pharmaceuticals Pvt Ltd last inspected by FDA?

The most recent FDA inspection document on file for Malladi Drugs & Pharmaceuticals Pvt Ltd is a Form 483 dated Oct 9, 2018, for the site in GajuJamandyant, India.

What did FDA cite at Malladi Drugs & Pharmaceuticals Pvt Ltd?

The regulations cited most in the observations on file for Malladi Drugs & Pharmaceuticals Pvt Ltd are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.192 (Production record review), 1 time.